Cart
sales@molnova.com
Teniloxazine
CAS No. 62473-79-4
Teniloxazine( —— )
Catalog No. M36116 CAS No. 62473-79-4
Teniloxazine is an orally available antidepressant compound with anti-hypoxic properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 494 | In Stock |
|
| 10MG | 715 | In Stock |
|
| 25MG | 1102 | In Stock |
|
| 50MG | 1460 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTeniloxazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionTeniloxazine is an orally available antidepressant compound with anti-hypoxic properties.
-
DescriptionTeniloxazine is an orally available antidepressant compound with anti-hypoxic properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number62473-79-4
-
Formula Weight289.39
-
Molecular FormulaC16H19NO2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(CC1CNCCO1)C2=C(CC3=CC=CS3)C=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Sodium succinate
Sodium succinate is the sodium salt form of succinate which is an important metabolite at the cross-road of several metabolic pathways and involved in the formation and elimination of reactive oxygen species.
-
Mofebutazone
Mofebutazone inhibits the immunological release of prostaglandins as well as leukotrienes.
-
GSK-25
GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).
